Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation

The dynamic evolution of therapeutic options including the use of vitamin K antagonists (VKA), non-vitamin K oral anticoagulants (NOAC), more potent antiplatelet drugs as well as new generation drug-eluting stents could lead to the view that the current recommendations on the management of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zalewski, Jarosław, Undas, Anetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133316/
https://www.ncbi.nlm.nih.gov/pubmed/27980542
http://dx.doi.org/10.5114/aic.2016.63626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133316/
https://www.ncbi.nlm.nih.gov/pubmed/27980542
http://dx.doi.org/10.5114/aic.2016.63626

Ejemplares similares